STOCKSCREENR

KYNB

NASDAQ

Kyntra Bio, Inc.

$7.27+0.22(+3.12%)Mkt Cap: $29.42M

Key Stats

Market Cap

$29.42M

P/E Ratio

-0.50

EPS

$-14.40

Dividend Yield

0.00%

52-Week Range

$4.85 — $12.60

Volume

6.28K

Avg Volume

29.68K

Beta

0.90

Price Alerts for KYNB

Get alerted when KYNB hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-0.50

Forward P/E

—

PEG Ratio

-0.01

P/S (TTM)

4.59

P/B (TTM)

6.60

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-1.62%

ROA (TTM)

1.53%

ROIC

—

Gross Margin

0.76%

Operating Margin

-7.13%

Net Margin

—

Debt/Equity

0.00

Current Ratio

3.39

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.30%

EPS Growth (5Y)

-0.19%

Sales Growth (3Y)

-0.48%

Sales Growth (5Y)

-0.28%

EPS Est (This Year)

$-13.54

EPS Est (Next Year)

$-10.25

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$21.99

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

4.05M

Float

3.56M

Free Float %

88.04%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Exchange

NASDAQ

IPO Date

2014-11-14

Employees

225

CEO

Thane Wettig

Index Membership

—

Website

https://www.kyntrabio.com

Kyntra Bio, Inc. (KYNB) is a healthcare company in the medical - pharmaceuticals industry listed on the NASDAQ. With a market capitalization of $29.42M, a P/E ratio of -0.50, KYNB is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare KYNB against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SDEV

Stablecoin Development Corp.

$1.24

-2.36%

$33.02M

0DOL.L

Biofrontera AG

$2.50

+1.63%

$111.43M

MSLE

Satellos Bioscience Inc. Common Stock

$7.95

+9.35%

$10.24M

0IL8.L

Kyntra Bio, Inc.

$7.23

+2.40%

$29.21M

0T6G.L

Q32 Bio Inc.

$5.39

+0.19%

$66.29M

0HIY.L

Atara Biotherapeutics, Inc.

$4.99

+8.54%

$40.84M

Frequently Asked Questions

What is Kyntra Bio, Inc.'s P/E ratio?

Kyntra Bio, Inc. (KYNB) has a trailing twelve-month (TTM) P/E ratio of -0.50. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Kyntra Bio, Inc. pay a dividend?

No, Kyntra Bio, Inc. (KYNB) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Kyntra Bio, Inc.'s market cap?

Kyntra Bio, Inc. (KYNB) has a market capitalization of $29.42 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.